{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["8(21)"],"submitter":["Chen J"],"pubmed_abstract":["<h4>Background</h4>This observational study aimed to share our experience in the surgical management of atrial functional mitral regurgitation (AFMR).<h4>Methods</h4>We retrospectively identified 82 AFMR patients (63.6±7.7 years) from June 2008 to November 2018 at our institution. Of these patients, 72.0% of them were classified as NYHA functional class III/IV, and all of them had persistent AF. All patients underwent mitral valve (MV) repair, and 52 (63.4%) received concomitant surgical ablation (SA). Patients were followed up for 26.1±27.6 months, and postoperative mitral regurgitation (MR) was assessed by echocardiography.<h4>Results</h4>There was no in-hospital mortality. The overall 1-year and 3-year survival rates were 97.5% and 92.9%, respectively, and 96.1% of patients recovered to"],"journal":["Annals of translational medicine"],"pagination":["1420"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7723636"],"repository":["biostudies-literature"],"pubmed_title":["Mitral valve repair and surgical ablation for atrial functional mitral regurgitation."],"pmcid":["PMC7723636"],"pubmed_authors":["Ding W","Yang Z","Lv M","Chen J","Wang C","Hong T","Lin Y","Wang Y","Wei L","Zhu S"],"additional_accession":[]},"is_claimable":false,"name":"Mitral valve repair and surgical ablation for atrial functional mitral regurgitation.","description":"<h4>Background</h4>This observational study aimed to share our experience in the surgical management of atrial functional mitral regurgitation (AFMR).<h4>Methods</h4>We retrospectively identified 82 AFMR patients (63.6±7.7 years) from June 2008 to November 2018 at our institution. Of these patients, 72.0% of them were classified as NYHA functional class III/IV, and all of them had persistent AF. All patients underwent mitral valve (MV) repair, and 52 (63.4%) received concomitant surgical ablation (SA). Patients were followed up for 26.1±27.6 months, and postoperative mitral regurgitation (MR) was assessed by echocardiography.<h4>Results</h4>There was no in-hospital mortality. The overall 1-year and 3-year survival rates were 97.5% and 92.9%, respectively, and 96.1% of patients recovered to","dates":{"release":"2020-01-01T00:00:00Z","publication":"2020 Nov","modification":"2025-04-04T23:46:51.213Z","creation":"2025-04-04T23:46:51.213Z"},"accession":"S-EPMC7723636","cross_references":{"pubmed":["33313165"],"doi":["10.21037/atm-20-2958"]}}